These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19714748)

  • 81. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study.
    Kristensen SL; Lindhardsen J; Ahlehoff O; Erichsen R; Lamberts M; Khalid U; Torp-Pedersen C; Nielsen OH; Gislason GH; Hansen PR
    Europace; 2014 Apr; 16(4):477-84. PubMed ID: 24108228
    [TBL] [Abstract][Full Text] [Related]  

  • 83. CD8
    Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
    Nguyen GC; Bernstein CN; Benchimol EI
    Inflamm Bowel Dis; 2017 Feb; 23(2):218-223. PubMed ID: 27997435
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Adenomas in patients with inflammatory bowel disease are associated with an increased risk of advanced neoplasia.
    van Schaik FD; Mooiweer E; van der Have M; Belderbos TD; Ten Kate FJ; Offerhaus GJ; Schipper ME; Dijkstra G; Pierik M; Stokkers PC; Ponsioen C; de Jong DJ; Hommes DW; van Bodegraven AA; Siersema PD; van Oijen MG; Oldenburg B;
    Inflamm Bowel Dis; 2013 Feb; 19(2):342-9. PubMed ID: 23340679
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care center.
    Hammoudi N; Lehmann-Che J; Lambert J; Amoyel M; Maggiori L; Salfati D; Tran Minh ML; Baudry C; Asesio N; Poirot B; Lourenco N; Corte H; Allez M; Aparicio T; Gornet JM
    Dig Liver Dis; 2023 Sep; 55(9):1280-1287. PubMed ID: 36872200
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.
    Söderlund S; Brandt L; Lapidus A; Karlén P; Broström O; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2009 May; 136(5):1561-7; quiz 1818-9. PubMed ID: 19422077
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
    Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
    Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany.
    Majek O; Gondos A; Jansen L; Emrich K; Holleczek B; Katalinic A; Nennecke A; Eberle A; Brenner H;
    PLoS One; 2013; 8(7):e68077. PubMed ID: 23861851
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.
    Renz BW; Thasler WE; Preissler G; Heide T; Khalil PN; Mikhailov M; Jauch KW; Kreis ME; Rentsch M; Kleespies A
    J Gastrointest Surg; 2013 May; 17(5):981-90. PubMed ID: 23475629
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Recurrence and survival rates of inflammatory bowel disease-associated colorectal cancer following postoperative chemotherapy: a comparative study.
    Dugum M; Lin J; Lopez R; Estfan B; Manilich E; Stocchi L; Shen B; Liu X
    Gastroenterol Rep (Oxf); 2017 Feb; 5(1):57-61. PubMed ID: 27279644
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Short-term survival after colorectal cancer in a screened versus unscreened population.
    Syse A; Soneji SS; Andrew AS; Tretli S; Baili P; Bynum JPW
    Scand J Public Health; 2019 Jul; 47(5):528-537. PubMed ID: 29360010
    [No Abstract]   [Full Text] [Related]  

  • 94. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Ji J; Sundquist J; Sundquist K
    Int J Cancer; 2018 May; 142(10):2003-2010. PubMed ID: 29270993
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pre-admission use of glucocorticoids and 30-day mortality following colorectal cancer surgery: a population-based Danish cohort study.
    Ostenfeld EB; Erichsen R; Thorlacius-Ussing O; Riis AH; Sørensen HT
    Aliment Pharmacol Ther; 2014 Apr; 39(8):843-53. PubMed ID: 24611938
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study.
    Wu XR; Zheng XB; Huang Y; Cao Q; Zhang HJ; Miao YL; Zou KF; Chen M; Zhang FM; Mei Q; Gonzalo D; Allende D; Hu PJ; Shen B; Liu XL; Lan P
    Gastroenterol Rep (Oxf); 2019 Feb; 7(1):67-73. PubMed ID: 30792868
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Colorectal cancer resection rates in patients with inflammatory bowel disease: a population-based study.
    Navaneethan U; Zhu X; Lourdusamy D; Lourdusamy V; Shen B; Kiran R
    Gastroenterol Rep (Oxf); 2018 Nov; 6(4):263-269. PubMed ID: 30430014
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Poor engagement and adherence predict neoplasia in inflammatory bowel disease: a case-control study.
    Young E; Jones E; Thomas M; Lawrence M; Andrews J
    Intern Med J; 2023 May; 53(5):731-737. PubMed ID: 35353446
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Morphological subtypes of colorectal low-grade intraepithelial neoplasia: diagnostic reproducibility, frequency and clinical impact.
    Lang-Schwarz C; Büttner-Herold M; Burian S; Erber R; Hartmann A; Jesinghaus M; Kamarádová K; Rubio CA; Seitz G; Sterlacci W; Vieth M; Bertz S
    J Clin Pathol; 2023 Nov; ():. PubMed ID: 37985140
    [TBL] [Abstract][Full Text] [Related]  

  • 100. CircRNAs as promising biomarkers of inflammatory bowel disease and its associated-colorectal cancer.
    Xu Y; Xu X; Ocansey DKW; Cao H; Qiu W; Tu Q; Mao F
    Am J Transl Res; 2021; 13(3):1580-1593. PubMed ID: 33841681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.